HCPCS Code G2023: Deleted Code for Specimen Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)

HCPCS code G0463 is the hospital facility fee billed for outpatient clinic visits at hospital-based facilities. This fee covers the use of hospital space, equipment, and overhead costs associated with the outpatient visit, distinct from the professional service fees billed separately by physicians. Medicare reimburses G0463 when it was still valid to offset the operational costs of providing outpatient care in hospital settings.

HCPCS code G2023 is used for specimen collection for SARS-CoV-2 (COVID-19) testing from any specimen source. It was specifically created for use by laboratories or testing sites that collect specimens but do not perform the testing themselves. This includes situations like drive-through testing centers. Note that CMS discontinued payment for G2023 and similar codes after the public health emergency ended, so verify current payer policies.

There are several HCPCS and CPT codes related to Respiratory Syncytial Virus (RSV). For billing RSV monoclonal antibody administration (such as nirsevimab), CPT codes 96380 and 96381 are used for intramuscular injections with counseling or without, respectively. RSV vaccines have specific CPT codes like 90678 or 90679 depending on the formulation. Monoclonal antibody products for RSV have HCPCS codes such as 90380 and 90381. The exact code depends on the type of RSV product administered.